Banque Transatlantique Sa Sana Biotechnology, Inc. Call Options Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SANA
# of Institutions
171Shares Held
115MCall Options Held
337KPut Options Held
337K-
Flagship Pioneering Inc. Cambridge, MA25MShares$52.3 Million17.82% of portfolio
-
Black Rock Inc. New York, NY11MShares$23.1 Million0.0% of portfolio
-
Baillie Gifford & CO10.2MShares$21.3 Million0.02% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$21.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.87MShares$16.4 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $398M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...